Carbazole compound and organic electroluminescent device thereof
By using carbazole compounds as the host material of the light-emitting layer in OLED devices, the problem of poor energy level matching between the host and guest materials is solved, thereby improving the driving voltage, luminous efficiency, and lifespan of OLED devices.
Patent Information
- Application Number
- CN202411059730.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-11-19
AI Technical Summary
In existing OLED devices, the energy level matching between the host and guest materials is poor, and the charge transport performance is inappropriate, which affects the luminous efficiency and lifespan of the devices.
Carbazole compounds are used as the main material for the light-emitting layer. They have appropriate HOMO and LUMO energy levels, good charge transport performance, and excellent thermal and chemical stability, and are applied in the organic functional layer of OLED devices.
It improves the driving voltage, luminous efficiency, and lifespan of OLED devices, and enhances the luminous efficiency and color purity of the devices.
Smart Images

Figure BDA0004977853800000011 
Figure BDA0004977853800000021 
Figure BDA0004977853800000067
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of organic photoelectric materials, and in particular to a carbazole compound and an organic electroluminescent device thereof. Background Art
[0002] Organic Light-Emitting Diode (OLED) has the characteristics of light weight, wide viewing angle, fast response speed, wide operating temperature range, low energy consumption, high efficiency, good color purity, high clarity and good flexibility. It has been widely used in the field of lighting and display and is considered by the industry to be one of the most promising display and lighting technologies.
[0003] The classic OLED device has a "sandwich" structure, with a light-emitting layer sandwiched between the cathode and anode electrodes, wherein the light-emitting layer contains a light-emitting substance (guest material). A certain working voltage is applied between the two electrodes, so that holes and electrons are injected from the anode and cathode respectively, and then reach the light-emitting layer, recombining to produce excitons, releasing energy, and under the action of the electric field, the excitons migrate and transfer the energy to the light-emitting substance. The electrons in the molecules of the light-emitting substance jump from the ground state to the excited state. Since the excited state is unstable, the electrons migrate back from the excited state to the ground state, thereby releasing energy and generating light emission. In general, the lowest unoccupied molecular orbital (LUMO) of the host material is higher than that of the guest material, and the highest occupied molecular orbital (HOMO) of the host material is lower than that of the guest material. In order to improve the performance of the device, more organic functional layers are provided between the anode and the light-emitting layer, and between the cathode and the light-emitting layer. The hole transport region is between the anode and the light-emitting layer, which mainly plays the role of injecting and transporting holes, including the hole injection layer, the hole transport layer, the light-emitting auxiliary layer, the electron blocking layer, etc.; the electron transport region is between the cathode and the light-emitting layer, which mainly plays the role of injecting and transporting electrons, including the electron injection layer, the electron transport layer, the hole blocking layer, etc.
[0004] In addition to setting an organic functional layer between the anode and the cathode, a covering layer is also set on the outside of the light-emitting electrode (away from the non-light-emitting electrode), which can further improve the light transmittance of the device, change the direction of light emission, etc., thereby improving the luminous efficiency and color purity of the device.
[0005] In order to further improve the luminous efficiency, color purity, service life and other performance of OLED devices, it is necessary to develop a host material with high energy level matching with the guest material and the adjacent organic functional layer, appropriate charge transfer performance and excellent stability. Summary of the invention
[0006] In order to solve the above technical problems, the present invention provides a carbazole compound, which has appropriate energy level and charge transfer performance, as well as good thermal stability and chemical stability. It is used as a main material of the light-emitting layer in an OLED device, and can improve the driving voltage, luminous efficiency and service life of the OLED device. It has a structure shown in formula (I):
[0007]
[0008] Wherein, the ring A, ring B, and ring C are independently selected from a substituted or unsubstituted C6-C30 aromatic ring, a substituted or unsubstituted C2-C30 heteroaromatic ring, and a ring formed by fusion of a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring;
[0009] The X1 and X2 are independently selected from a single bond, O, S, CR a R b or NL-Ar, and at least one of them is not a single bond, the L is selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, a substituted or unsubstituted C3-C20 aliphatic ring fused with a C6-C30 aromatic ring; the R a , R b , Ar is independently selected from a substituted or unsubstituted C1-C20 straight or branched alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, a substituted or unsubstituted silyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C2-C30 heteroaryl group, a substituted or unsubstituted C3-C20 aliphatic ring fused with a C6-C30 aromatic ring, or the R a , R b Can bond to each other to form a substituted or unsubstituted saturated or unsaturated C3-C6 ring;
[0010] The Ar1 and Ar2 are independently selected from one of the following groups:
[0011]
[0012] wherein X is selected from O, S or N-R2 at each occurrence, the same or different; Y is selected from N or C-R3 at each occurrence, the same or different; R1, R2, R3 are selected from hydrogen atom, deuterium atom, halogen atom, cyano group, substituted or unsubstituted C1-C20 straight chain or branched alkyl group, substituted or unsubstituted C3-C20 cycloalkyl group, substituted or unsubstituted silyl group, substituted or unsubstituted C6-C30 aryl group, substituted or unsubstituted C2-C30 heteroaryl group, substituted or unsubstituted C3-C20 aliphatic ring and C6-C30 aromatic ring fused monovalent group at each occurrence; Ring E is selected from substituted or unsubstituted C6-C30 aromatic ring, substituted or unsubstituted C3-C20 aliphatic ring and C6-C30 aromatic ring fused ring at each occurrence, the same or different;
[0013] The Cy is selected from a substituted or unsubstituted C6-C30 aromatic ring, a substituted or unsubstituted C2-C30 heteroaromatic ring, and a ring formed by fusion of a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring;
[0014] The L1, L2, and L3 are independently selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, and a divalent group formed by condensing a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring.
[0015] The present invention also provides an organic electroluminescent device, comprising an anode, a cathode and an organic functional layer, wherein the organic functional layer comprises one or more of a hole transport region, a light-emitting layer, an electron transport region located between the anode and the cathode, and a covering layer on the side of the cathode facing away from the anode, and the organic functional layer contains one or more of the carbazole compounds described in the present invention.
[0016] Beneficial effects:
[0017] The carbazole compounds provided by the present invention have appropriate HOMO energy levels and LUMO energy levels, can be well matched with adjacent organic functional layers, and also have appropriate charge transfer performance, and also have good thermal stability and chemical stability. As the main material in the light-emitting layer, they can well improve the driving voltage, luminous efficiency and service life of OLED devices. DETAILED DESCRIPTION
[0018] The following will be clearly and completely described in conjunction with the technical solutions of the specific embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of the present invention.
[0019] In the compounds of the present invention, any atom not designated as a specific isotope is included as any stable isotope of that atom, and includes atoms in both their natural isotopic abundance and unnatural abundance. Taking hydrogen as an example, all naturally occurring compounds contain about 0.0156 atomic % deuterium per hydrogen atom.
[0020] In the present invention, the use of "H" and "hydrogen atom" means that the hydrogen atoms in the chemical structure contain no more than natural abundance of deuterium atoms or tritium atoms, for example, no more than 0.0156 atomic % of deuterium. "D" and "deuterium atom" mean that the abundance of deuterium content is above the natural abundance, for example, any value exceeding 0.1 atomic %, exceeding 1 atomic %, exceeding 10 atomic %, for example, about 95 atomic % of which is deuterium. "T" and "tritium atom" mean that the abundance of tritium content is above the natural abundance, for example, any value exceeding 0.1 atomic %, exceeding 1 atomic %, exceeding 10 atomic %, for example, about 95% of which is tritium. In the present invention, the omitted hydrogen represents "H" or "hydrogen atom".
[0021] The halogen atom mentioned in the present invention refers to a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
[0022] The "silyl group" mentioned in the present invention refers to a -SiH3 group, and the "substituted or unsubstituted silyl group" mentioned herein refers to one or more H groups on the silyl group being substituted or unsubstituted by a substituent.
[0023] The alkyl group described in the present invention refers to a hydrocarbon group formed by missing a hydrogen atom in an alkane molecule, which can be a straight-chain alkyl group or a branched-chain alkyl group, preferably having 1 to 15 carbon atoms, more preferably 1 to 12 carbon atoms, and particularly preferably 1 to 6 carbon atoms. The straight-chain alkyl group includes methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, undecyl, dodecyl, etc., but not limited thereto; the branched-chain alkyl group includes isopropyl, isobutyl, sec-butyl, tert-butyl, isomeric groups of n-pentyl, isomeric groups of n-hexyl, isomeric groups of n-heptyl, isomeric groups of n-octyl, isomeric groups of n-nonyl, isomeric groups of n-decyl, etc., but not limited thereto. The above-mentioned alkyl group is preferably methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl.
[0024] The cycloalkyl group of the present invention refers to a hydrocarbon group formed by removing a hydrogen atom from a cycloalkane molecule, preferably having 3 to 15 carbon atoms, more preferably 3 to 12 carbon atoms, and particularly preferably 5 to 10 carbon atoms. Examples may include cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, adamantyl, norbornane, etc., but are not limited thereto. The above cycloalkyl group is preferably cyclopentane, cyclohexane, 1-adamantyl, 2-adamantyl, norbornane.
[0025] The cycloalkenyl group of the present invention refers to a hydrocarbon group formed by removing a hydrogen atom from a cycloolefin molecule, preferably having 3 to 15 carbon atoms, more preferably 3 to 12 carbon atoms, and particularly preferably 5 to 10 carbon atoms. Examples may include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, etc., but are not limited thereto. The above-mentioned cycloalkyl group is preferably cyclopentenyl or cyclohexenyl.
[0026] The heterocycloalkyl group described in the present invention refers to a group formed by missing a hydrogen atom from a heterocyclic molecule whose atoms constituting the ring contain at least one heteroatom in addition to carbon atoms. The heteroatoms include nitrogen atoms, oxygen atoms, sulfur atoms, silicon atoms, selenium atoms, phosphorus atoms, etc., preferably nitrogen atoms, oxygen atoms, and sulfur atoms. It preferably contains 1 to 3 heteroatoms, more preferably 1 to 2 heteroatoms, and particularly preferably 1 heteroatom. It preferably has 3 to 15 ring atoms, more preferably 3 to 12 ring atoms, and particularly preferably 5 to 6 ring atoms. Examples may include oxirane, thioethane, propylene, tetrahydropyrrolyl, piperidinyl, morpholinyl, thiomorpholinyl, piperazinyl, etc., but are not limited thereto. The above-mentioned heterocyclic group is preferably tetrahydropyrrolyl, piperidinyl, morpholinyl, thiomorpholinyl, and piperazinyl.
[0027] The aromatic group described in the present invention refers to a general term for a monovalent group remaining after removing a hydrogen atom from the aromatic carbon nucleus of an aromatic compound molecule, which can be a monocyclic aromatic group, a polycyclic aromatic group, a condensed aromatic group, or a condensed group of an aromatic group and an aliphatic ring, preferably having 6 to 25 carbon atoms, more preferably 6 to 20 carbon atoms, particularly preferably 6 to 14 carbon atoms, and most preferably 6 to 12 carbon atoms. The monocyclic aromatic group refers to an aromatic group having only one aromatic ring in the molecule, for example, phenyl, etc., but not limited thereto; the polycyclic aromatic group refers to an aromatic group containing two or more independent aromatic rings in the molecule, for example, biphenyl, terphenyl, etc., but not limited thereto; the condensed-ring aromatic group refers to an aromatic group containing two or more aromatic rings in the molecule and fused to each other by sharing two adjacent carbon atoms, for example, naphthyl, anthracenyl, phenanthrenyl, pyrene, perylenyl, fluorenyl, benzofluorenyl, triphenylene, fluoranthenyl, 9,9-dimethylfluorenyl, 9,9-diphenylfluorenyl, spirobifluorenyl, spiro-cyclopentyl-fluorenyl, spiro-cyclohexyl-fluorenyl, spiro-adamantyl-fluorenyl, spiro-cyclopentenyl-fluorenyl, spiro-cyclohexenyl-fluorenyl, etc., but not limited thereto. The above-mentioned aryl group is preferably phenyl, biphenyl, terphenyl, 1-naphthyl, 2-naphthyl, 9,9-dimethylfluorenyl, 9,9-diphenylfluorenyl, spirobifluorenyl, spiro-cyclopentyl-fluorenyl, spiro-cyclohexyl-fluorenyl, spiro-adamantyl-fluorenyl, spiro-cyclopentenyl-fluorenyl, spiro-cyclohexenyl-fluorenyl.
[0028] The heteroaryl group described in the present invention refers to a general term for a group in which one or more aromatic carbon atoms in the aromatic group are replaced by heteroatoms, wherein the heteroatoms include but are not limited to oxygen, sulfur, nitrogen, silicon, selenium or phosphorus atoms, preferably having 1 to 25 carbon atoms, more preferably 2 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, and most preferably 3 to 12 carbon atoms. The attachment site of the heteroaryl group may be located on a ring-forming carbon atom or a ring-forming nitrogen atom, and the heteroaryl group may be a monocyclic heteroaryl group, a polycyclic heteroaryl group or a condensed-ring heteroaryl group. The monocyclic heteroaryl groups include furanyl, thienyl, pyrrolyl, imidazolyl, pyridyl, pyrimidinyl, etc., but are not limited thereto; the polycyclic heteroaryl groups include phenylfuranyl, phenylthienyl, etc., but are not limited thereto; the condensed ring heteroaryl groups include benzothienyl, benzofuranyl, indolyl, benzoxazolyl, benzimidazolyl, benzothiazolyl, dibenzofuranyl, benzodibenzofuranyl, dibenzothienyl, benzodibenzothienyl, carbazolyl, benzocarbazolyl, acridinyl, 9,10-dihydroacridinyl, phenoxazinyl, phenothiazinyl, phenoxathiyl, quinolyl, isoquinolyl, quinoxalinyl, quinazolinyl, etc., but are not limited thereto. The heteroaryl group is preferably benzothienyl, benzofuranyl, indolyl, benzoxazolyl, benzimidazolyl, benzothiazolyl, dibenzofuranyl, dibenzothienyl, pyridyl, quinolyl, isoquinolyl, quinoxalinyl, or quinazolinyl.
[0029] The monovalent group formed by the fusion of an aliphatic ring and an aromatic ring of the present invention refers to a general term for a monovalent group after aliphatic rings (cycloalkanes, cycloolefins, cycloalkynes) and aromatic rings are fused together and a hydrogen atom is removed. The aromatic ring preferably has 6 to 25 carbon atoms, more preferably 6 to 20 carbon atoms, particularly preferably 6 to 14 carbon atoms, and most preferably 6 to 12 carbon atoms, which may include benzene, naphthalene, anthracene, phenanthrene, etc., but is not limited thereto; the aliphatic ring preferably has 3 to 9 carbon atoms, more preferably 5 to 7 carbon atoms, which may include cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclopropene, cyclobutene, cyclopentene, cyclohexene, cycloheptene, cyclopropyne, cyclobutyne, cyclopentyne, cyclohexyne, cycloheptyne. Preferably, examples of the monovalent group formed by the fusion of an aliphatic ring and an aromatic ring may include benzocyclopropyl, benzocyclobutyl, benzocyclopentyl, benzocyclohexyl, benzocycloheptyl, benzocyclopentenyl, benzocyclohexenyl, benzocycloheptenyl, naphthocyclopropyl, naphthocyclobutyl, naphthocyclopentyl, naphthocyclohexyl, etc., but are not limited thereto.
[0030] The arylene group described in the present invention means an aryl group having two bonding sites, that is, a divalent group. The description of the aryl group provided above can be applied thereto, except that the arylene group is a divalent group.
[0031] The heteroarylene group described in the present invention means a heteroaryl group having two bonding sites, that is, a divalent group. The description of the heteroaryl group provided above can be applied thereto, except that the heteroarylene group is a divalent group.
[0032] The divalent group formed by the fusion of an aliphatic ring and an aromatic ring described in the present invention refers to a group formed by the fusion of an aliphatic ring and an aromatic ring having two bonding sites, that is, a divalent group. The description of the group formed by the fusion of an aliphatic ring and an aromatic ring provided above can be applied to it, except that the divalent group formed by the fusion of an aliphatic ring and an aromatic ring is a divalent group.
[0033] The "substitution" described in the present invention refers to the replacement of a hydrogen atom in certain functional groups by another atom or functional group (i.e., a substituent), and the position of the substitution is not limited as long as the position is the position where the hydrogen atom is replaced, and when two or more are substituted, the two or more substituents may be the same or different from each other.
[0034] The term "substituted or unsubstituted" as used herein means not substituted or substituted by one or more substituents selected from the group consisting of: a deuterium atom, a halogen atom, an amino group, a cyano group, a nitro group, a substituted or unsubstituted C1-C30 alkyl group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C3-C30 cycloalkenyl group, a substituted or unsubstituted C3-C30 heterocycloalkyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C6-C60 aryloxy group, a substituted or unsubstituted C2-C60 heteroaryl group, a substituted or unsubstituted silyl group, preferably a deuterium atom, a halogen atom, a cyano group, a nitro group, a C1-C12 alkyl group, a C3-C12 cycloalkyl group, a C3-C12 cycloalkenyl group, C3-C12 heterocycloalkyl, C6-C30 aryl, C2-C30 heteroaryl, substituted or unsubstituted silyl, when substituted by multiple substituents, the multiple substituents are the same or different from each other; preferably, it means not substituted or substituted by one or more substituents selected from the group consisting of: deuterium atom, fluorine atom, cyano group, methyl, trifluoromethyl, deuterated methyl, ethyl, deuterated ethyl, n-propyl, isopropyl, deuterated isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, deuterated tert-butyl, cyclopropane, methyl substituted cyclopropane, ethyl substituted cyclopropane, deuterated cyclopropane, cyclobutane, methyl substituted cyclobutane, ethyl substituted cyclobutane, deuterated cyclobutane, cyclopentane, methyl substituted cyclopropane pentyl, ethyl-substituted cyclopentyl, deuterated cyclopentyl, cyclohexyl, methyl-substituted cyclohexyl, ethyl-substituted cyclohexyl, n-propyl-substituted cyclohexyl, n-butyl-substituted cyclohexyl, cyclohexane-substituted cyclohexyl, deuterated cyclohexyl, cycloheptyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, adamantyl, methyl-substituted adamantyl, ethyl-substituted adamantyl, deuterated adamantyl, norbornyl, methyl-substituted norbornyl, ethyl-substituted norbornyl, deuterated norbornyl, tetrahydropyrrolyl, piperidinyl, morpholinyl, thiomorpholinyl, methyl-substituted piperazinyl, ethyl-substituted piperazinyl, phenyl-substituted piperazinyl, naphthyl-substituted piperazinyl, phenyl, deuterated phenyl, naphthyl, deuterated naphthyl, anthracenyl, Deuterated anthracenyl, phenanthryl, deuterated phenanthryl, triphenylene, pyrenyl, 9,9-dimethylfluorenyl, 9,9-diphenylfluorenyl, spirobifluorenyl, spiro-cyclopentyl-fluorenyl, spiro-cyclohexyl-fluorenyl, spiro-adamantyl-fluorenyl, spiro-cyclopentenyl-fluorenyl, spiro-cyclohexenyl-fluorenyl, N-phenylcarbazolyl, benzofuranyl, benzothienyl, indolyl, dibenzofuranyl, benzodibenzofuranyl, dibenzothienyl, benzodibenzothienyl, benzoxazolyl, benzothiazolyl, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinazolinyl, quinoxalinyl, trimethylsilyl, triphenylsilyl. When substituted by multiple substituents, the multiple substituents are the same or different from each other, and two adjacent substituents may be connected to form a ring.
[0035] In this specification, when the position of a substituent or a connection site on a ring is not fixed, it means that it can be connected to any of the optional sites of the ring. For example, Can be expressed Can be expressed Can be expressed And so on.
[0036] In this specification, when a substituent or a bond at a connection site runs through two or more rings, it indicates that it can be connected to any of the two or more rings, specifically, it can be connected to any of the corresponding optional sites of the ring. For example, Can be expressed Can be expressed Can be expressed And so on.
[0037] The linked ring structure (e.g., a saturated or unsaturated C3-C10 carbon ring, a substituted or unsubstituted saturated or unsaturated C3-C6 aliphatic ring) of the present invention means that the groups are connected to each other by chemical bonds, and optionally form double bonds / triple bonds, and can constitute aromatic groups, as shown in the following examples:
[0038]
[0039] In the present invention, the ring formed by connection can be an aromatic ring system, an aliphatic ring system or a ring system formed by the fusion of the two. The ring formed by connection can be a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a spiro ring or a fused ring, such as benzene, naphthalene, indene, cyclopentene, cyclopentane, cyclopentane acene, cyclohexene, cyclohexane, cyclohexane acene, pyridine, quinoline, isoquinoline, benzofuran, benzothiophene, dibenzofuran, dibenzothiophene, phenanthrene or pyrene, but is not limited thereto.
[0040] In the present specification, "at least one" includes one, two, three, four, five, six, seven, eight or more.
[0041] The present invention provides a carbazole compound having a structure shown in formula (I):
[0042]
[0043] Wherein, the ring A, ring B, and ring C are independently selected from a substituted or unsubstituted C6-C30 aromatic ring, a substituted or unsubstituted C2-C30 heteroaromatic ring, and a ring formed by fusion of a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring;
[0044] The X1 and X2 are independently selected from a single bond, O, S, CR a R b or NL-Ar, and at least one of them is not a single bond, the L is selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, a substituted or unsubstituted C3-C20 aliphatic ring fused with a C6-C30 aromatic ring; the R a , R b , Ar is independently selected from a substituted or unsubstituted C1-C20 straight or branched alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, a substituted or unsubstituted silyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C2-C30 heteroaryl group, a substituted or unsubstituted C3-C20 aliphatic ring fused with a C6-C30 aromatic ring, or the R a , R b Can bond to each other to form a substituted or unsubstituted saturated or unsaturated C3-C6 ring;
[0045] The Ar1 and Ar2 are independently selected from one of the following groups:
[0046]
[0047] wherein X is selected from O, S or N-R2 at each occurrence, the same or different; Y is selected from N or C-R3 at each occurrence, the same or different; R1, R2, R3 are selected from hydrogen atom, deuterium atom, halogen atom, cyano group, substituted or unsubstituted C1-C20 straight chain or branched alkyl group, substituted or unsubstituted C3-C20 cycloalkyl group, substituted or unsubstituted silyl group, substituted or unsubstituted C6-C30 aryl group, substituted or unsubstituted C2-C30 heteroaryl group, substituted or unsubstituted C3-C20 aliphatic ring and C6-C30 aromatic ring fused monovalent group at each occurrence; Ring E is selected from substituted or unsubstituted C6-C30 aromatic ring, substituted or unsubstituted C3-C20 aliphatic ring and C6-C30 aromatic ring fused ring at each occurrence, the same or different;
[0048] The Cy is selected from a substituted or unsubstituted C6-C30 aromatic ring, a substituted or unsubstituted C2-C30 heteroaromatic ring, and a ring formed by fusion of a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring;
[0049] The L1, L2, and L3 are independently selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, and a divalent group formed by condensing a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring.
[0050] Preferably, the substituents in the "substituted or unsubstituted" are independently selected from one of the following groups: a deuterium atom, a halogen atom, a cyano group, a substituted or unsubstituted C1-C12 straight or branched alkyl group, a substituted or unsubstituted C3-C12 cycloalkyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C2-C30 heteroaryl group, a substituted or unsubstituted C3-C20 aliphatic ring fused with a C6-C30 aromatic ring, a substituted or unsubstituted silyl group, and the substituents are one or more. When there are multiple substituents, the multiple substituents are the same or different. When there are multiple substituents, two adjacent substituents can be connected to form a substituted or unsubstituted saturated or unsaturated C3-C7 carbocyclic ring.
[0051] Preferably, the substituent in the "substituted or unsubstituted" is independently selected from one of the following groups: deuterium atom; fluorine atom; cyano group; methyl substituted or unsubstituted by deuterium atom or fluorine atom; ethyl; n-propyl group; isopropyl substituted or unsubstituted by deuterium atom or fluorine atom; n-butyl; sec-butyl; isobutyl group; tert-butyl substituted or unsubstituted by deuterium atom or fluorine atom; cyclopropane group; cyclobutane group; cyclopentane group; cyclohexane group; adamantyl group; norbornane group; phenyl substituted or unsubstituted by one or more of deuterium atom, fluorine atom, cyano group, methyl, ethyl, isopropyl, tert-butyl, adamantyl group and norbornane group; one or more substituted or unsubstituted naphthyl; anthracenyl substituted or unsubstituted by one or more of a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl group, a tert-butyl group, an adamantyl group, and a norbornyl group; a phenanthryl substituted or unsubstituted by one or more of a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl group, a tert-butyl group, an adamantyl group, and a norbornyl group; a triphenylene substituted or unsubstituted by one or more of a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl group, a tert-butyl group, an adamantyl group, and a norbornyl group; a 9,9-dimethylfluorenyl substituted or unsubstituted by one or more of a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl group, a tert-butyl group, an adamantyl group, and a norbornyl group; 9,9-diphenylfluorenyl substituted or unsubstituted by one or more of a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl, a tert-butyl group, an adamantyl group, and a norbornyl group; spirobifluorenyl substituted or unsubstituted by one or more of a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl, a tert-butyl group, an adamantyl group, and a norbornyl group; benzofuranyl substituted or unsubstituted by one or more of a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl, a tert-butyl group, an adamantyl group, and a norbornyl group; benzothiophene substituted or unsubstituted by one or more of a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl, a tert-butyl group, an adamantyl group, and a norbornyl group; a dibenzofuranyl group which is substituted or unsubstituted by one or more of the following: a dibenzothiophenyl group which is substituted or unsubstituted by one or more of the following: a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl group, a tert-butyl group, an adamantyl group, and a norbornyl group; an N-phenylcarbazolyl group which is substituted or unsubstituted by one or more of the following: a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl group, a tert-butyl group, an adamantyl group, and a norbornyl group; an indanyl group which is substituted or unsubstituted by one or more of the following: a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl group, a tert-butyl group, an adamantyl group, and a norbornyl group; a tetrahydronaphthyl group which is substituted or unsubstituted by one or more of the following: a deuterium atom, a fluorine atom, a cyano group, a methyl group, an ethyl group, an isopropyl group, a tert-butyl group, an adamantyl group, and a norbornyl group;Silyl substituted or unsubstituted by one or more of methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, phenyl, deuterated phenyl, methyl-substituted phenyl, tert-butyl-substituted phenyl, fluorine-substituted phenyl, cyano-substituted phenyl, adamantyl-substituted phenyl, norbornyl-substituted phenyl, naphthyl, deuterated naphthyl, anthracenyl, phenanthryl, biphenyl, pyridyl, pyrimidyl, dibenzofuranyl, dibenzothienyl, 9,9-dimethylfluorenyl, wherein the substituent is one or more, and when there are multiple substituents, the multiple substituents are the same or different, and when there are multiple substituents, two adjacent substituents can be connected to form a substituted or unsubstituted saturated or unsaturated C3-C6 carbon ring. ;
[0052] Preferably, the ring A and the ring C are independently selected from one of the substituted or unsubstituted structures shown below: a benzene ring, a naphthalene ring, an anthracene ring, a phenanthrene ring, a pyridine ring, a pyrimidine ring, a quinoline ring, an isoquinoline ring, a quinoxaline ring, a quinazoline ring, an indane ring, and a tetralin ring; and the ring B is selected from one of the substituted or unsubstituted structures shown below: a benzene ring, a naphthalene ring, and a pyridine ring.
[0053] Preferably, ring B is selected from a substituted or unsubstituted naphthalene ring, and the two side rings are fused to the same benzene ring of the naphthalene ring or to different benzene rings of the naphthalene ring.
[0054] Preferably, the carbazole compound has one of the structures shown below:
[0055]
[0056] Preferably, Ar1 and Ar2 are independently selected from one of the following groups:
[0057]
[0058]
[0059] Wherein, each occurrence of X is the same or different selected from O, S or N-R2; each occurrence of Y is the same or different selected from N or C-R3;
[0060] Each time a0 appears, it is selected from 0, 1, 2, 3 or 4 in the same or different manner; each time b0 appears, it is selected from 0, 1, 2, 3, 4, 5 or 6 in the same or different manner; each time c0 appears, it is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8 in the same or different manner; each time d0 appears, it is selected from 0, 1, 2 or 3 in the same or different manner; each time e0 appears, it is selected from 0, 1 or 2 in the same or different manner;
[0061] The R1, R2, R3, R ZEach time it occurs, it is identically or differently selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a substituted or unsubstituted C1-C12 straight or branched alkyl group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted silyl group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, and a monovalent group formed by a substituted or unsubstituted C3-C10 aliphatic ring and a C6-C20 aromatic ring.
[0062] Preferably, Ar1 and Ar2 are independently selected from one of the following groups:
[0063]
[0064]
[0065] Wherein, each time a appears, it is selected from 0, 1, 2, 3 or 4 in the same or different manner; each time b appears, it is selected from 0, 1 or 2 in the same or different manner; each time c appears, it is selected from 0, 1, 2 or 3 in the same or different manner; each time d appears, it is selected from 0 or 1 in the same or different manner;
[0066] Each time X appears, it is selected from O, S or N-R2 in the same or different manner; each time Y appears, it is selected from N or C-R3 in the same or different manner;
[0067] The R1, R2, R3, R Z Each time it occurs, it is selected, identically or differently, from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a substituted or unsubstituted C1-C6 straight-chain or branched alkyl group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted silyl group, a substituted or unsubstituted C6-C18 aryl group, a substituted or unsubstituted C2-C18 heteroaryl group, or a monovalent group formed by the fusion of a substituted or unsubstituted C3-C7 aliphatic ring and a C6-C18 aromatic ring.
[0068] Preferably, Ar1 and Ar2 are independently selected from one of the following groups:
[0069]
[0070]
[0071]
[0072] Wherein, each time a appears, it is selected from 0, 1, 2, 3 or 4 in the same or different manner; each time b appears, it is selected from 0, 1 or 2 in the same or different manner; each time c appears, it is selected from 0, 1, 2 or 3 in the same or different manner; each time d appears, it is selected from 0 or 1 in the same or different manner;
[0073] The R1, R3, R Z Each occurrence is identically or differently selected from hydrogen atom; deuterium atom; fluorine atom; cyano group; methyl group which may be substituted or unsubstituted by one or more of deuterium atom and fluorine atom; ethyl group; n-propyl group; isopropyl group which may be substituted or unsubstituted by one or more of deuterium atom and fluorine atom; n-butyl group; sec-butyl group; isobutyl group; tert-butyl group which may be substituted or unsubstituted by one or more of deuterium atom and fluorine atom; cyclopropane group; cyclobutane group; cyclopentane group; cyclohexane group; the following substituents which may be substituted or unsubstituted by one or more of deuterium atom, fluorine atom, methyl group, ethyl group, isopropyl group and tert-butyl group: adamantyl group, nor-ic a styryl group; ...
[0074] Each time the R2 appears, it is identically or differently selected from methyl substituted or unsubstituted by one or more of deuterium atoms and fluorine atoms; ethyl; n-propyl; isopropyl substituted or unsubstituted by one or more of deuterium atoms and fluorine atoms; n-butyl; sec-butyl; isobutyl; tert-butyl substituted or unsubstituted by one or more of deuterium atoms and fluorine atoms; cyclopropane; cyclobutane; cyclopentane; cyclohexane; the following substituents substituted or unsubstituted by one or more of deuterium atoms, fluorine atoms, methyl, ethyl, isopropyl, tert-butyl: adamantyl, norbornyl; The following substituents may be substituted or unsubstituted with one or more of the following: phenyl, biphenyl, diphenylphenyl, naphthyl, anthracenyl, phenanthryl, pyridyl, pyrimidinyl, quinolyl, isoquinolyl, quinoxalinyl, quinazolinyl, benzofuranyl, benzothiophenyl, indanyl, tetrahydronaphthyl, and silyl.
[0075] Preferably, the Cy is selected from a substituted or unsubstituted C6-C18 aromatic ring, a substituted or unsubstituted C2-C18 heteroaromatic ring, and a ring formed by fusion of a substituted or unsubstituted C3-C7 aliphatic ring and a C6-C18 aromatic ring.
[0076] Preferably, the Cy is selected from one of the substituted or unsubstituted structures shown below: benzene ring, naphthalene ring, anthracene ring, phenanthrene ring, triphenylene ring, pyrene ring, pyridine ring, pyrimidine ring, pyrazine ring, triazine ring, quinoline ring, isoquinoline ring, quinoxaline ring, quinazoline ring, indane ring, and tetralin ring.
[0077] Preferably, the Selected from one of the following groups:
[0078]
[0079]
[0080]
[0081] Wherein, each time a appears, it is selected from 0, 1, 2, 3 or 4 in the same or different manner; each time b appears, it is selected from 0, 1 or 2 in the same or different manner; each time c appears, it is selected from 0, 1, 2 or 3 in the same or different manner; each time d appears, it is selected from 0 or 1 in the same or different manner;
[0082] The R1, R3, R Z Each occurrence is identically or differently selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, a cyclopropane group, a cyclobutane group, a cyclopentane group, a cyclohexane group, an adamantyl group, a norbornyl group, a phenyl group, a deuterated phenyl group, a fluorine-substituted phenyl group, a methyl-substituted phenyl group, a tert-butyl-substituted phenyl group, a cyano-substituted phenyl group, a biphenyl group, a deuterated biphenyl group, a methyl-substituted biphenyl group, a tert-butyl-substituted biphenyl group, a naphthyl group, One of deuterated naphthyl, anthracenyl, deuterated anthracenyl, phenanthryl, deuterated phenanthryl, pyridyl, deuterated pyridyl, pyrimidinyl, deuterated pyrimidinyl, diphenylpyrimidinyl, quinolyl, deuterated quinolyl, isoquinolyl, deuterated isoquinolyl, quinoxalinyl, phenyl-substituted quinoxalinyl, quinazolinyl, phenyl-substituted quinazolinyl, benzofuranyl, deuterated benzofuranyl, benzothienyl, deuterated benzothienyl, indanyl, deuterated indanyl, tetrahydronaphthyl, deuterated tetrahydronaphthyl, and trimethylsilyl;
[0083] The R2 described above, when it appears each time, is identically or differently selected from methyl, deuterated methyl, trifluoromethyl, ethyl, isopropyl, tert-butyl, deuterated tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, deuterated phenyl, fluorine-substituted phenyl, methyl-substituted phenyl, tert-butyl-substituted phenyl, cyano-substituted phenyl, biphenyl, deuterated biphenyl, methyl-substituted biphenyl, tert-butyl-substituted biphenyl, naphthyl, deuterated naphthyl, anthracenyl, deuterated anthracenyl, phenanthryl, deuterated phenanthryl, pyridyl, deuterated pyridyl, pyrimidinyl, deuterated pyrimidinyl, diphenylpyrimidinyl, quinolyl, deuterated quinolyl, isoquinolyl, deuterated isoquinolyl, quinoxalinyl, phenyl-substituted quinoxalinyl, quinazolinyl, phenyl-substituted quinazolinyl, benzofuranyl, deuterated benzofuranyl, benzothienyl, deuterated benzothienyl, indanyl, deuterated indanyl, tetrahydronaphthyl, deuterated tetrahydronaphthyl, trimethylsilyl;
[0084] The a 11 Each time it occurs, it is selected from 0, 1, 2 or 3, either identically or differently;
[0085] The R 11 Each occurrence is identically or differently selected from one of a hydrogen atom, a deuterium atom, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, and a trimethylsilyl group;
[0086] Each time L2 and L3 appear, they are identical or different and are selected from a single bond or one of the following groups:
[0087]
[0088] Among them, the a 21 Each occurrence is identically or differently selected from 0, 1, 2, 3 or 4; said b 21 Each time it occurs, it is selected from 0, 1, 2 or 3, the same or different; 21 Each occurrence is identically or differently selected from 0, 1 or 2; said d 21 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5 or 6; said e 21 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8;
[0089] The R 21 , R 22 Each time it occurs, it is identically or differently selected from one of the group consisting of a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, a cyclopropane group, a cyclobutane group, a cyclopentane group, a cyclohexane group, an adamantyl group, a norbornyl group, and a trimethylsilyl group.
[0090] Preferably, each time L2 and L3 appear, they are identically or differently selected from a single bond or one of the following groups:
[0091]
[0092] Preferably, Selected from one of the following groups:
[0093]
[0094] Preferably, the R a , R b , Ar is independently selected from methyl, deuterated methyl, trifluoromethyl, ethyl, n-propyl, isopropyl, deuterated isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, deuterated tert-butyl, One of the following groups:
[0095]
[0096]
[0097]
[0098] Among them, the a 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4 or 5; said b 31 Each occurrence is identically or differently selected from 0, 1, 2, 3 or 4; said c 31 Each occurrence is identically or differently selected from 0, 1, 2 or 3; said d 31 Each occurrence is identically or differently selected from 0, 1 or 2; said e 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5 or 6; said f 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; said g 31 Each time it occurs, it is selected from 0 or 1 identically or differently; 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14;
[0099] The R 31Each occurrence is identically or differently selected from one of the group consisting of a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, an adamantyl group, a norbornyl group, a phenyl group, a deuterated phenyl group, a fluorine-substituted phenyl group, a methyl-substituted phenyl group, a tert-butyl-substituted phenyl group, a cyano-substituted phenyl group, a naphthyl group, a deuterated naphthyl group, an indanyl group, a deuterated indanyl group, a tetrahydronaphthyl group, a deuterated tetrahydronaphthyl group, a pyridyl group, a deuterated pyridyl group, a pyrimidyl group, a deuterated pyrimidyl group, a trimethylsilyl group, and a triphenylsilyl group;
[0100] The R 32 Each occurrence is identically or differently selected from one of hydrogen, deuterium, fluorine, cyano, methyl, deuterated methyl, trifluoromethyl, ethyl, isopropyl, tert-butyl, deuterated tert-butyl, cyclopropane, cyclobutane, cyclopentane, cyclohexane, adamantyl, and norbornyl;
[0101] The R 33 Each occurrence is identically or differently selected from one of the following: methyl, deuterated methyl, trifluoromethyl, ethyl, isopropyl, tert-butyl, deuterated tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, deuterated phenyl, fluorine-substituted phenyl, methyl-substituted phenyl, tert-butyl-substituted phenyl, cyano-substituted phenyl, biphenyl, deuterated biphenyl, fluorine-substituted biphenyl, methyl-substituted biphenyl, tert-butyl-substituted biphenyl, cyano-substituted biphenyl, naphthyl, deuterated naphthyl, indanyl, deuterated indanyl, tetrahydronaphthyl, deuterated tetrahydronaphthyl, pyridyl, deuterated pyridyl, pyrimidinyl, deuterated pyrimidinyl, trimethylsilyl, triphenylsilyl.
[0102] Preferably, each time L1 and L appear, they are identically or differently selected from a single bond or one of the following groups:
[0103]
[0104]
[0105] Among them, the a 41 Each occurrence is identically or differently selected from 0, 1, 2, 3 or 4; said b 41 Each time it occurs, it is selected from 0, 1, 2 or 3, the same or different; 41 Each occurrence is identically or differently selected from 0, 1 or 2; said d 41 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5 or 6; said e 41 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; said f41 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; said g 41 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14;
[0106] The R 41 The R of the present invention 31 The definition of is the same as;
[0107] The R 42 The R of the present invention 32 The definition of is the same as;
[0108] The R 43 The R of the present invention 33 The definition is the same.
[0109] Preferably, each time L1 and L appear, they are identically or differently selected from a single bond or one of the following groups:
[0110]
[0111] Preferably, the carbazole compound is selected from one of the following compounds:
[0112]
[0113]
[0114]
[0115]
[0116]
[0117]
[0118]
[0119]
[0120]
[0121]
[0122]
[0123]
[0124]
[0125]
[0126]
[0127]
[0128]
[0129]
[0130] The above lists only some specific structural forms of the carbazole compounds of the present invention, but the present invention is not limited to these chemical structures listed, and all those based on formula (I) and having substituents as defined in the present invention should be included.
[0131] The carbazole compounds of the present invention can be prepared by the following synthetic route:
[0132]
[0133] In the above synthetic route, the X' is selected from a chlorine atom, a bromine atom or an iodine atom;
[0134] The ring A, ring B, ring C, X1, X2, Ar1, Ar2, Cy, and L1-L3 are all as described in the present invention.
[0135] In the above synthesis route, the compound (Y1) and the halide (Y2) can be reacted by CN coupling reaction to obtain the carbazole compound of the present invention.
[0136] The above reaction route adopts the reaction type commonly used in organic synthesis, and the reaction conditions (for example, the selection of types of reaction solvents, catalysts, ligands, bases, etc., the amount used, and the order and method of addition) are not particularly limited. The above preparation method has easy-to-obtain raw materials, a simple preparation process, and excellent yield. The present invention can also be synthesized using conventional reaction types in other organic syntheses without particular restrictions, and the above is only an example of a synthetic route.
[0137] The present invention also provides an organic electroluminescent device, comprising an anode, a cathode and an organic functional layer, wherein the organic functional layer comprises one or more of a hole transport region, a light-emitting layer, an electron transport region located between the anode and the cathode, and a covering layer on the side of the cathode facing away from the anode, and the organic functional layer contains one or more of the carbazole compounds described in the present invention.
[0138] Preferably, the organic functional layer comprises a hole transport region, a light emitting layer and an electron transport region located between the anode and the cathode, and the light emitting layer contains one or more of the carbazole compounds described in the present invention.
[0139] Preferably, the organic functional layer includes a hole transport region, a light-emitting layer, an electron transport region located between the anode and the cathode, and a covering layer on the side of the cathode facing away from the anode, and the covering layer contains one or more of the carbazole compounds described in the present invention.
[0140] The hole transport region of the present invention includes at least one layer of a hole injection layer, a hole transport layer and a light-emitting auxiliary layer.
[0141] The hole injection layer of the present invention may be a single-layer structure composed of a single substance, or a single-layer structure or a multi-layer structure composed of different substances. Triarylamine compounds, porphyrin compounds, styrene compounds, polythiophene and its derivatives, phthalocyanine derivatives, axialene compounds and other substances with high hole injection properties may be used, for example, 4,4',4"-tris[2-naphthylphenylamino]triphenylamine (2-TNATA), 2,3,6,7,10,11-hexacyano-1,4,5,8,9,12-hexaazatriphenylene (HATCN), copper phthalocyanine (CuPC), 2,3,5,6-tetrafluoro-7,7',8,8'-tetracyanodimethyl-p-benzoquinone (F4-TCNQ), poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonic acid) (PEDOT / PSS), compounds HT-1 to HT-19, compounds p-1 to p-3, but are not limited thereto.
[0142]
[0143]
[0144] The hole transport layer of the present invention may be a single-layer structure composed of a single substance, or a single-layer structure or a multi-layer structure composed of different substances. A triarylamine compound may be used, or other materials with a hole mobility of 10 -6 cm 2 / Vs or above, for example, N,N'-diphenyl-N,N'-di(3-methylphenyl)-1,1'-biphenyl-4,4'-diamine (TPD), N,N'-diphenyl-N,N'-(1-naphthyl)-1,1'-biphenyl-4,4'-diamine (NPB), 4,4'4"-tris(N,N-diphenylamino)triphenylamine (TDATA), and compounds HT-1 to HT-19 shown above, but not limited thereto.
[0145] The light-emitting auxiliary layer of the present invention may be a single-layer structure composed of a single substance, or a single-layer structure or a multi-layer structure composed of different substances. Triarylamine compounds, spirofluorene derivatives, dibenzofuran derivatives can be used, and other substances with appropriate HOMO and T1 energy levels can also be used. Examples include TPD, NPB, N4, N4-bis([1,1'-biphenyl]-4-yl)-N4'-phenyl N4'-[1,1':4',1"-terphenyl]-4-yl-[1,1'-biphenyl]-4,4'-diamine, N-([1,1'-diphenyl]-4-yl)-N-(9,9-dimethyl-9H-furan-2-yl)-9,9'-spirobifluorene-2-amine, N,N-di([1,1'-biphenyl]-4-yl)-3'-(dibenzo[b,d]furan-4-yl)-[1,1'-biphenyl]-4-amine, and compounds HT-1 to HT-19 shown above, but are not limited to these.
[0146] The light-emitting layer of the present invention includes a guest material and a host material, and a dual host material formed by two host materials can be used. The guest material can use a fluorescent compound, such as a pyrene derivative, a fluoranthene derivative, an aromatic amine derivative, etc. Examples include 10-(2-benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinolinazine-11-one (C545T), 4,4'-bis(9-ethyl-3-carbazole vinyl)-1,1'-biphenyl (BCzVBi), 4, 4'-bis[4-(di-p-tolylamino)phenylvinyl]biphenyl (DPAVBi), etc., phosphorescent materials can also be used, such as metal complexes such as iridium complexes, osmium complexes, and platinum complexes. Examples include bis(4,6-difluorophenylpyridine-N,C2)picolinoyliridium (FIrpic), tris(2-phenylpyridine)iridium (Ir(ppy)3), di(2-phenylpyridine)iridium acetylacetonate (Ir(ppy)2(acac)), etc. The host material preferably uses a substance with a higher LUMO and a lower HOMO than that of the guest material, such as a metal complex such as an aluminum complex or a zinc complex, a heterocyclic compound such as an oxadiazole derivative, a benzoxazole derivative, a benzothiazole derivative or a benzimidazole derivative, a condensed aromatic compound such as a carbazole derivative or anthracene derivative, an aromatic amine compound such as a triarylamine derivative or a condensed polycyclic aromatic amine derivative, examples of which include Alq3, BAlq, TPBI, TPD, 4,4'-di(9-carbazole)biphenyl (CBP), 4,4',4"-tri(carbazole-9-yl)triphenylamine (TCTA), 9,10-di(2-naphthyl)anthracene (ADN), and the carbazole compounds described in the present invention, but are not limited thereto.
[0147] The electron transport region of the present invention comprises at least one layer of an electron injection layer, an electron transport layer and a hole blocking layer.
[0148] The electron injection layer of the present invention can be a single-layer structure composed of a single substance, or a single-layer structure or a multi-layer structure composed of different substances, and can be selected from one or more of the following substances: alkali metals, alkaline earth metals, alkali metal halides, alkaline earth metal halides, alkali metal oxides, alkaline earth metal oxides, alkali metal salts, alkaline earth metal salts, and other substances with high electron injection properties. Examples include Li, Ca, Sr, LiF, CsF, CaF2, BaO, Li2CO3, CaCO3, Li2C2O4, Cs2C2O4, CsAlF4, LiOx, Yb, Tb, etc., but are not limited thereto.
[0149] The electron transport layer described in the present invention can be a single-layer structure composed of a single substance, or a single-layer structure or a multi-layer structure composed of different substances. Aluminum complexes, lithium complexes, beryllium complexes, zinc complexes, oxazole derivatives, benzoxazole derivatives, thiazole derivatives, benzothiazole derivatives, imidazole derivatives, benzimidazole derivatives, carbazole derivatives, phenanthroline derivatives, polymer compounds, etc. with high electron transport properties can be used. Examples include 8-hydroxyquinoline aluminum (Alq3), bis(10-hydroxybenzo[h]quinoline)beryllium (BeBq2), bis(2-methyl-8-hydroxyquinoline-N1,O8)-(1,1'-biphenyl-4-hydroxy)aluminum (BAlq), and 2-(4-biphenyl)-5-phenyloxadiazole (PBD), but are not limited to these.
[0150] The hole blocking layer of the present invention can be a single-layer structure composed of a single substance, or a single-layer structure or a multi-layer structure composed of different substances. The selected material requires a T1 energy level higher than the light-emitting layer, so as to block the energy loss of the light-emitting layer. In addition, the HOMO energy level of the selected material must be lower than the HOMO energy level of the main material of the light-emitting layer, so as to play a role in blocking holes. Furthermore, the electron mobility of the hole blocking layer material used is 10 -6 cm 2 / Vs or more, which is conducive to the transmission of electrons. One or more of the following substances can be selected: aluminum complex, lithium complex, beryllium complex, oxazole derivative, benzoxazole derivative, thiazole derivative, benzothiazole derivative, imidazole derivative, benzimidazole derivative, phenanthroline derivative, polymer compound, etc. Examples include 1,3,5-tris(1-phenyl-1H-benzimidazole-2-yl)benzene (TPBI), BAlq, etc., but are not limited thereto.
[0151] The anode described in the present invention can be a reflective anode, such as a reflective film formed by silver (Ag), magnesium (Mg), aluminum (Al), gold (Au), nickel (Ni), chromium (Cr), ytterbium (Yb) or their alloys, or it can be a layer structure with a high work function and is transparent or translucent, such as a layer structure formed by indium tin oxide (ITO), indium zinc oxide (ZnO), zinc oxide (ZnO), aluminum zinc oxide (AZO), indium gallium oxide (IGO), indium oxide (In2O3) or tin oxide (SnO2). It depends on the type of device to be prepared. If the device to be prepared is a bottom-emitting device (emitting light on the anode side), a transparent or translucent anode needs to be made. If the device to be prepared is a top-emitting device (emitting light on the cathode side), a reflective anode needs to be made.
[0152] The cathode described in the present invention can be a thin film with a low work function made of lithium, calcium, lithium fluoride / calcium, lithium fluoride / aluminum, aluminum, silver, magnesium, magnesium-silver alloy, etc., and can be made into a reflective electrode, a transparent electrode or a semi-transparent electrode by adjusting the thickness of the film. If a bottom-emitting device is to be prepared, a reflective cathode needs to be made. If a top-emitting device is to be prepared, a transparent or semi-transparent cathode needs to be made.
[0153] The covering layer of the present invention can be a single-layer structure composed of a single substance, or a single-layer structure or a multi-layer structure composed of different substances. The covering layer material can use organic or inorganic substances with an appropriate refractive index, such as metal halides, oxides, nitrides, nitrogen oxides, sulfides, selenides, aromatic compounds, heteroaromatic compounds, aromatic amine compounds, etc. Examples include LiF, CsF, MgF2, CaF2, CsCl, CuI, V2O5, WO3, MoO3, TiO2, ZrO, ZnO, SiO2, SiN, ZnS, Alq3, compound CP-1, compound CP-2, compound CP-3, compound CP-4, and the carbazole compounds of the present invention, but are not limited thereto.
[0154]
[0155] The above-mentioned organic layers, cathode, and anode can be prepared by any method including vacuum evaporation, inkjet printing, sputtering, plasma, ion plating, spin coating, dipping, screen printing, etc. There is no special restriction on the thickness of each layer as long as good device performance is obtained.
[0156] The above-mentioned organic layers are preferably prepared by vacuum evaporation, inkjet printing or spin coating.
[0157] The thickness of each organic layer is usually 5 nm to 100 um, preferably 10 nm to 200 nm. The thickness of the anode and cathode is adjusted according to the required transparency.
[0158] The organic electroluminescent device provided by the present invention can be applied to fields such as lighting and display, and can be specifically listed as smartphone display screens, tablet computer display screens, smart wearable device display screens, large-size displays such as televisions, VR, and car taillights.
[0159] The technical scheme and technical effects of the present invention are further illustrated below with reference to embodiments and comparative examples.
[0160] The mass spectra of the compounds of the present invention were determined using a G2-Si quadrupole tandem time-of-flight high-resolution mass spectrometer from Waters, UK, with chloroform as the solvent;
[0161] The elemental analysis was performed using a Vario EL cube organic element analyzer from Elementar, Germany, with a sample mass of 5 to 10 mg.
[0162] Synthesis Example 1: Synthesis of Intermediate a
[0163]
[0164] Under nitrogen protection, AA-357 (20.17 g, 100 mmol), BB-357 (32.78 g, 120 mmol), copper powder (8.26 g, 130 mmol), 18-crown ether-6 (2.65 g, 10 mmol), K2CO3 (16.59 g, 120 mmol), and DMF (300 mL) were added to the reaction bottle and refluxed for 12 hours. After the reaction was completed, it was cooled to room temperature, water was added, and after extraction with dichloromethane, the organic layer was washed with water in turn, dried over anhydrous magnesium sulfate, the solvent was removed under reduced pressure, and purified by silica gel column chromatography (ethyl acetate: petroleum ether = 3:1) to obtain CC-357 (29.93 g, yield 76%); HPLC detected the solid purity ≧99.76%. Mass spectrum m / z: 393.0931 (theoretical value: 393.0920).
[0165] Under nitrogen protection, CC-357 (31.51 g, 80 mmol), biboronic acid pinacol ester (20.32 g, 80 mmol), Pd (dppf) Cl2 (0.29 g, 0.4 mmol), KOAc (15.71 g, 160 mmol), DMF (400 mL) were added to the reaction bottle and stirred for 6 hours under reflux. After the reaction was completed, it was cooled to room temperature, the solvent was removed under reduced pressure, water was added, and it was extracted with dichloromethane. The organic layer was dried with anhydrous magnesium sulfate, the solvent was removed under reduced pressure, and recrystallized with toluene: ethanol = 3:1 to obtain DD-357 (33.01 g, 85%); HPLC detected the solid purity ≧99.77%. Mass spectrum m / z: 485.2175 (theoretical value: 485.2162).
[0166] Under nitrogen protection, DD-357 (24.27 g, 50 mmol), EE-357 (10.80 g, 50 mmol), Pd(PPh3)4 (0.58 g, 0.5 mmol), K2CO3 (13.82 g, 100 mmol), THF (225 mL), and water (110 mL) were added to the reaction bottle and stirred for 7 hours under reflux. After the reaction was completed, the mixture was cooled to room temperature, the solvent was removed under reduced pressure, water was added, and the mixture was extracted with dichloromethane. The organic layer was dried over anhydrous magnesium sulfate, the solvent was removed under reduced pressure, and the mixture was recrystallized with toluene:n-hexane = 4:1 to obtain FF-357 (18.55 g, 75%); HPLC detected the solid purity to be ≧99.82%. Mass spectrum m / z: 494.1649 (theoretical value: 494.1630).
[0167] Under nitrogen protection, FF-357 (14.84 g, 30 mmol), triphenylphosphine (19.67 g, 75 mmol), and o-dichlorobenzene (120 mL) were added to the reaction bottle and stirred for 12 hours under reflux. After the reaction was completed, the mixture was cooled to room temperature, the solvent was removed under reduced pressure, water was added, and the mixture was extracted with dichloromethane. The organic layer was dried over anhydrous magnesium sulfate, the solvent was removed under reduced pressure, and the mixture was recrystallized with ethyl acetate: n-hexane = 6:1 to obtain intermediate a-357 (10.55 g, 76%); HPLC detected the solid purity to be ≧99.88%. Mass spectrum m / z: 462.1745 (theoretical value: 462.1732).
[0168] By replacing the raw materials accordingly and following the synthesis method of intermediate a-357, other intermediates a can be obtained, as shown in the following table:
[0169]
[0170] Synthesis Example 2: Synthesis of Intermediate b
[0171] Synthesis Example 2-1:
[0172]
[0173] Under argon atmosphere, A-36 (13.52 g, 50 mmol), bipyraclostrobin (25.40 g, 100 mmol), Pd(dppf)Cl2 (0.18 g, 0.25 mmol), KOAc (12.27 g, 125 mmol), THF (380 mL) were added to the reaction bottle and refluxed for 7 hours. After the reaction was completed, it was cooled and water was added. The mixture was filtered and dried in a vacuum oven. The crude product was separated and purified by silica gel column (petroleum ether: ethyl acetate = 1:1) to obtain B-36 (16.95 g, yield 93%); HPLC purity ≥ 99.89%. Mass spectrum m / z: 364.1796 (theoretical value: 364.1784).
[0174] Under argon atmosphere, add B-36 (10.93 g, 30 mmol), C-36 (11.88 g, 60 mmol), Pd (dppf) Cl2 (0.66 g, 0.9 mmol), potassium phosphate tribasic aqueous solution (19.11 g, 90 mmol), DMF (210 mL) to the reaction bottle, and reflux for 24 hours. After the reaction is complete, cool to room temperature, add water, extract with dichloromethane, dry the extract with anhydrous sodium sulfate, filter, and evaporate the filtrate. The crude product is separated and purified by silica gel column (dichloromethane: petroleum ether = 1:4) to obtain intermediate b-36 (9.15 g, yield 88%); HPLC purity ≥ 99.87%. Mass spectrum m / z: 346.0515 (theoretical value: 346.0509).
[0175] By replacing the raw materials accordingly and following the synthesis method of intermediate b-36, other intermediates b can be obtained, as shown in the following table:
[0176]
[0177]
[0178] Synthesis Example 2-2:
[0179]
[0180] Under argon atmosphere, A-95 (47.61 g, 150 mmol), biboronic acid pinacol ester (45.71 g, 180 mmol), Pd(dppf)Cl2 (0.55 g, 0.75 mmol), KOAc (29.44 g, 300 mmol), THF (1 L) were added to the reaction bottle and refluxed for 6 hours. After the reaction was completed, it was cooled and water was added, extracted with dichloromethane, the organic phases were combined, dried with anhydrous magnesium sulfate, the solvent was removed in vacuo, and the crude product was separated and purified by silica gel column (dichloromethane: n-hexane = 1:3) to obtain B-95 (38.09 g, yield 80%); HPLC purity ≥ 99.91%. Mass spectrum m / z: 316.0019 (theoretical value: 316.0037).
[0181] Under argon atmosphere, add B-95 (31.60 g, 100 mmol), C-95 (31.33 g, 120 mmol), Pd(PPh3)4 (0.46 g, 0.4 mmol), potassium carbonate aqueous solution (29.02 g, 210 mmol), toluene (740 mL) to the reaction bottle and reflux for 24 hours. After the reaction is completed, cool to room temperature, add water to quench the reaction, extract with dichloromethane, combine the organic phases, dry the organic phase with anhydrous magnesium sulfate, filter, and evaporating the filtrate. Purify by silica gel column (dichloromethane: petroleum ether = 1:1) to obtain D-95 (25.00 g, 77%); HPLC purity ≥ 99.68%. Mass spectrum m / z: 322.9158 (theoretical value: 322.9171).
[0182] Under argon atmosphere, D-95 (16.23 g, 50 mmol), bipyraclostrobin (15.24 g, 60 mmol), Pd(dppf)Cl2 (0.09 g, 0.12 mmol), KOAc (9.81 g, 100 mmol), THF (250 mL) were added to the reaction bottle and refluxed for 6.5 hours. After the reaction was completed, it was cooled and water was added. The mixture was filtered and dried in a vacuum oven. The crude product was separated and purified by silica gel column (petroleum ether: ethyl acetate = 1:2) to obtain E-95 (14.68 g, yield 79%); HPLC purity ≥ 99.90%. Mass spectrum m / z: 371.0932 (theoretical value: 371.0918).
[0183] Under argon atmosphere, E-95 (11.15 g, 30 mmol), F-95 (9.05 g, 31.2 mmol), Pd(PPh3)4 (0.41 g, 0.44 mmol), and an aqueous solution of sodium carbonate (7.95 g, 75 mmol) were added to the reaction bottle and refluxed for 20 hours. After the reaction was complete, the mixture was cooled to room temperature, water was added, and the mixture was extracted with dichloromethane. The extract was dried over anhydrous sodium sulfate, filtered, and the filtrate was evaporated by rotary evaporation. The crude product was separated and purified by a silica gel column (dichloromethane: n-hexane = 1:3) to obtain intermediate b-95 (11.60 g, yield 85%); HPLC purity ≥ 99.79%. Mass spectrum m / z: 454.0350 (theoretical value: 454.0365).
[0184] By replacing the raw materials accordingly and following the synthesis method of intermediate b-95, other intermediates b can be obtained, as shown in the following table:
[0185]
[0186] Synthesis Example 2-3:
[0187]
[0188] Under argon atmosphere, A-36 (40.55 g, 150 mmol), biboronic acid pinacol ester (76.18 g, 300 mmol), Pd(dppf)Cl2 (0.55 g, 0.75 mmol), KOAc (36.80 g, 375 mmol), THF (1.14 L) were added to the reaction bottle and refluxed for 7 hours. After the reaction was completed, it was cooled and water was added, the mixture was filtered and dried in a vacuum oven, and the crude product was separated and purified by silica gel column (petroleum ether: ethyl acetate = 1:1) to obtain B-36 (50.30 g, yield 92%); HPLC purity ≥ 99.88%. Mass spectrum m / z: 364.1798 (theoretical value: 364.1784).
[0189] Under argon atmosphere, add B-36 (36.45g, 100mmol), C-519 (39.60g, 200mmol), Pd(dppf)Cl2 (2.20g, 3mmol), potassium phosphate tribasic aqueous solution (63.68g, 300mmol), DMF (700mL) to the reaction bottle, and reflux for 24 hours. After the reaction is complete, cool to room temperature, add water, extract with dichloromethane, dry the extract with anhydrous sodium sulfate, filter, and evaporate the filtrate. The crude product is separated and purified by silica gel column (dichloromethane: petroleum ether = 1:4) to obtain b-519 (30.86g, yield 89%); HPLC purity ≥99.85%. Mass spectrum m / z: 346.0520 (theoretical value: 346.0509).
[0190] Under argon atmosphere, b-519 (17.34 g, 50 mmol), biboronic acid pinacol ester (13.20 g, 52 mmol), KOAc (7.36 g, 75 mmol), Pd(PPh3)4 (1.73 g, 1.5 mmol), ethanol (60 mL), water (60 mL), toluene (180 mL) were added to the reaction bottle and refluxed for 6 h. After the reaction was completed, it was cooled to room temperature, water was added, extracted with toluene, the organic phases were combined, dried with anhydrous sodium sulfate, filtered, and the filtrate was concentrated until no solvent was evaporated. The crude product was separated and purified by silica gel column (dichloromethane: heptane = 1:2) to obtain E-110 (18.85 g, 86%); HPLC purity ≥ 99.87%. Mass spectrum m / z: 438.1739 (theoretical value: 438.1751).
[0191] Under argon atmosphere, E-110 (13.15 g, 30 mmol), F-110 (5.74 g, 30 mmol), KOAc (4.42 g, 45 mmol), Pd(PPh3)4 (1.04 g, 0.9 mmol), ethanol (38 mL), water (38 mL), toluene (115 mL) were added to the reaction bottle and refluxed for 7 h. After the reaction was completed, it was cooled to room temperature, water was added, extracted with dichloromethane, the organic phases were combined, dried with anhydrous sodium sulfate, filtered, the filtrate was concentrated, and recrystallized with methanol to obtain intermediate b-110 (9.51 g, 75%); HPLC purity ≥99.78%. Mass spectrum m / z: 422.0840 (theoretical value: 422.0822).
[0192] By replacing the raw materials accordingly and following the synthesis method of intermediate b-110, other intermediates b can be obtained, as shown in the following table:
[0193]
[0194] Synthesis Example 3: Synthesis of Compound 36
[0195]
[0196] Under nitrogen protection, a-36 (3.32 g, 10 mmol), b-36 (4.16 g, 12 mmol), copper powder (0.83 g, 13 mmol), 18-crown ether-6 (0.26 g, 1 mmol), K2CO3 (1.66 g, 12 mmol), DMF (50 mL) were added to the reaction bottle and stirred for 20 hours under reflux. After the reaction was completed, it was cooled to room temperature, water was added, and after extraction with dichloromethane, the organic layer was washed with water in turn, dried over anhydrous magnesium sulfate, the solvent was removed under reduced pressure, and recrystallized from toluene to obtain compound 36 (4.88 g, 76%); HPLC detected the solid purity ≧99.95%. Mass spectrum m / z: 642.2071 (theoretical value: 642.2056). Theoretical element content (%) C 44 H 26 N4O2: C, 82.23; H, 4.08; N, 8.72. Measured element content (%): C, 82.27; H, 4.06; N, 8.70.
[0197] Synthesis Example 4: Synthesis of Compound 59
[0198]
[0199] Replace a-36 with an equal molar amount of a-59, replace b-36 with an equal molar amount of b-59, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 59 (5.64 g, 75%); HPLC detection of solid purity ≧99.96%. Mass spectrum m / z: 751.1768 (theoretical value: 751.1752). Theoretical element content (%) C 50 H 29 N3OS2: C, 79.87; H, 3.89; N, 5.59. Measured element content (%): C, 79.85; H, 3.87; N, 5.62.
[0200] Synthesis Example 5: Synthesis of Compound 95
[0201]
[0202] Replace a-36 with an equal molar amount of a-95, replace b-36 with an equal molar amount of b-95, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 95 (6.06 g, 72%); HPLC detection of solid purity ≧99.93%. Mass spectrum m / z: 840.2009 (theoretical value: 840.2018). Theoretical element content (%) C 56 H 32 N4OS2: C, 79.98; H, 3.84; N, 6.66. Measured element content (%): C, 79.96; H, 3.89; N, 6.63.
[0203] Synthesis Example 6: Synthesis of Compound 107
[0204]
[0205] Replace a-36 with an equal molar amount of a-107, replace b-36 with an equal molar amount of b-107, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 107 (5.11 g, 74%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 690.2319 (theoretical value: 690.2307). Theoretical element content (%) C 50 H 30 N2O2: C, 86.94; H, 4.38; N, 4.06. Measured element content (%): C, 86.97; H, 4.35; N, 4.04.
[0206] Synthesis Example 7: Synthesis of Compound 110
[0207]
[0208] Replace b-36 with an equal molar amount of b-110, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 110 (5.53 g, 77%); HPLC detection of solid purity ≧99.96%. Mass spectrum m / z: 718.2355 (theoretical value: 718.2369). Theoretical element content (%) C 50 H 30 N4O2: C, 83.55; H, 4.21; N, 7.79. Measured element content (%): C, 83.59; H, 4.20; N, 7.74.
[0209] Synthesis Example 8: Synthesis of Compound 145
[0210]
[0211] Replace b-36 with an equal molar amount of b-145, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 145 (5.80 g, 73%); HPLC detection of solid purity ≧99.93%. Mass spectrum m / z: 794.2693 (theoretical value: 794.2682). Theoretical element content (%) C 56 H 34 N4O2: C, 84.61; H, 4.31; N, 7.05. Measured element content (%): C, 84.67; H, 4.28; N, 7.01.
[0212] Synthesis Example 9: Synthesis of Compound 176
[0213]
[0214] Replace b-36 with an equal molar amount of b-176, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 176 (5.39 g, 75%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 718.2349 (theoretical value: 718.2369). Theoretical element content (%) C 50 H 30 N4O2: C, 83.55; H, 4.21; N, 7.79. Measured element content (%): C, 83.51; H, 4.23; N, 7.77.
[0215] Synthesis Example 10: Synthesis of Compound 191
[0216]
[0217] Replace a-36 with an equal molar amount of a-191, replace b-36 with an equal molar amount of b-191, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 191 (5.60 g, 78%); HPLC detection of solid purity ≧99.93%. Mass spectrum m / z: 717.2679 (theoretical value: 717.2668). Theoretical element content (%) C 53 H 35 NO2: C, 88.68; H, 4.91; N, 1.95. Measured element content (%): C, 88.65; H, 4.90; N, 1.98.
[0218] Synthesis Example 11: Synthesis of Compound 288
[0219]
[0220] Replace a-36 with an equal molar amount of a-288, replace b-36 with an equal molar amount of b-288, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 288 (5.87 g, 74%); HPLC detection of solid purity ≧99.91%. Mass spectrum m / z: 792.3018 (theoretical value: 792.3001). Theoretical element content (%) C 56 H 36 N6: C, 84.82; H, 4.58; N, 10.60. Measured element content (%): C, 84.84; H, 4.53; N, 10.64.
[0221] Synthesis Example 12: Synthesis of Compound 301
[0222]
[0223] Replace a-36 with an equal molar amount of a-288, replace b-36 with an equal molar amount of b-301, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 301 (6.62 g, 76%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 870.2984 (theoretical value: 870.2995). Theoretical element content (%) C 62 H 38 N4O2: C, 85.50; H, 4.40; N, 6.43. Measured element content (%): C, 85.48; H, 4.41; N, 6.46.
[0224] Synthesis Example 13: Synthesis of Compound 317
[0225]
[0226] Replace a-36 with an equal molar amount of a-288, replace b-36 with an equal molar amount of b-191, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 317 (5.59 g, 78%); HPLC detection of solid purity ≧99.95%. Mass spectrum m / z: 716.2449 (theoretical value: 716.2464). Theoretical element content (%) C 52 H 32 N2O2: C, 87.13; H, 4.50; N, 3.91. Measured element content (%): C, 87.17; H, 4.51; N, 3.88.
[0227] Synthesis Example 14: Synthesis of Compound 357
[0228]
[0229] Replace a-36 with an equal molar amount of a-357, replace b-36 with an equal molar amount of b-357, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 357 (5.87 g, 76%); HPLC detection of solid purity ≧99.92%. Mass spectrum m / z: 772.2486 (theoretical value: 772.2474). Theoretical element content (%) C 53 H 32 N4O3: C, 82.37; H, 4.17; N, 7.25. Measured element content (%): C, 82.39; H, 4.19; N, 7.20.
[0230] Synthesis Example 15: Synthesis of Compound 420
[0231]
[0232] Replace a-36 with an equal molar amount of a-420, replace b-36 with an equal molar amount of b-420, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 420 (5.83 g, 78%); HPLC detection of solid purity ≧99.95%. Mass spectrum m / z: 746.2693 (theoretical value: 746.2682). Theoretical element content (%) C 52 H 34 N4O2: C, 83.63; H, 4.59; N, 7.50. Measured element content (%): C, 83.67; H, 4.56; N, 7.48.
[0233] Synthesis Example 16: Synthesis of Compound 435
[0234]
[0235] Replace a-36 with an equal molar amount of a-435, replace b-36 with an equal molar amount of b-435, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 435 (5.65 g, 74%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 762.1811 (theoretical value: 762.1800). Theoretical element content (%) C 52 H 30 N2OS2: C, 81.86; H, 3.96; N, 3.67. Measured element content (%): C, 81.89; H, 3.99; N, 3.62.
[0236] Synthesis Example 17: Synthesis of Compound 466
[0237]
[0238] Replace a-36 with an equal molar amount of a-466, replace b-36 with an equal molar amount of b-466, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 466 (4.99 g, 72%); HPLC detection of solid purity ≧99.93%. Mass spectrum m / z: 692.2203 (theoretical value: 692.2212). Theoretical element content (%) C 48 H 28 N4O2: C, 83.22; H, 4.07; N, 8.09. Measured element content (%): C, 83.21; H, 4.04; N, 8.13.
[0239] Synthesis Example 18: Synthesis of Compound 467
[0240]
[0241] Replace a-36 with an equal molar amount of a-467, replace b-36 with an equal molar amount of b-466, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 467 (6.11 g, 70%); HPLC detection of solid purity ≧99.91%. Mass spectrum m / z: 872.2771 (theoretical value: 872.2787). Theoretical element content (%) C 61 H 36 N4O3: C, 83.93; H, 4.16; N, 6.42. Measured element content (%): C, 83.91; H, 4.19; N, 6.40.
[0242] Synthesis Example 19: Synthesis of Compound 477
[0243]
[0244] Replace a-36 with an equal molar amount of a-477, replace b-36 with an equal molar amount of D-191, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 477 (6.45 g, 74%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 870.2870 (theoretical value: 870.2882). Theoretical element content (%) C 63 H 38 N2O3: C, 86.88; H, 4.40; N, 3.22. Measured element content (%): C, 86.85; H, 4.38; N, 3.29.
[0245] Synthesis Example 20: Synthesis of Compound 506
[0246]
[0247] Replace a-36 with an equal molar amount of a-506, replace b-36 with an equal molar amount of b-506, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 506 (5.90 g, 72%); HPLC detection of solid purity ≧99.91%. Mass spectrum m / z: 818.2671 (theoretical value: 818.2682). Theoretical element content (%) C 58 H 34 N4O2: C, 85.07; H, 4.18; N, 6.84. Measured element content (%): C, 85.05; H, 4.15; N, 6.88.
[0248] Synthesis Example 21: Synthesis of Compound 519
[0249]
[0250] Replace a-36 with an equal molar amount of a-519, replace b-36 with an equal molar amount of b-519, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 519 (5.27 g, 76%); HPLC detection of solid purity ≧99.95%. Mass spectrum m / z: 692.2225 (theoretical value: 692.2212). Theoretical element content (%) C 48 H 28 N4O2: C, 83.22; H, 4.07; N, 8.09. Measured element content (%): C, 83.27; H, 4.04; N, 8.04.
[0251] Synthesis Example 22: Synthesis of Compound 521
[0252]
[0253] Replace a-36 with an equal molar amount of a-521, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 521 (5.92 g, 77%); HPLC detection of solid purity ≧99.95%. Mass spectrum m / z: 768.2539 (theoretical value: 768.2525). Theoretical element content (%) C 54 H 32 N4O2: C, 84.36; H, 4.20; N, 7.29. Measured element content (%): C, 84.39; H, 4.23; N, 7.24.
[0254] Synthesis Example 23: Synthesis of Compound 546
[0255]
[0256] Replace a-36 with an equal molar amount of a-546, replace b-36 with an equal molar amount of b-546, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 546 (5.98 g, 73%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 818.2694 (theoretical value: 818.2682). Theoretical element content (%) C 58 H 34 N4O2: C, 85.07; H, 4.18; N, 6.84. Measured element content (%): C, 85.05; H, 4.12; N, 6.89.
[0257] Synthesis Example 24: Synthesis of Compound 550
[0258]
[0259] Replace a-36 with an equal molar amount of a-550, replace b-36 with an equal molar amount of b-110, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 550 (6.22 g, 76%); HPLC detection of solid purity ≧99.95%. Mass spectrum m / z: 818.2695 (theoretical value: 818.2682). Theoretical element content (%) C 58 H 34 N4O2: C, 85.07; H, 4.18; N, 6.84. Measured element content (%): C, 85.02; H, 4.19; N, 6.87.
[0260] Synthesis Example 25: Synthesis of Compound 555
[0261]
[0262] Replace a-36 with an equal molar amount of a-519, replace b-36 with an equal molar amount of b-555, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 555 (5.90 g, 74%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 796.2849 (theoretical value: 796.2838). Theoretical element content (%) C 56 H 36 N4O2: C, 84.40; H, 4.55; N, 7.03. Measured element content (%): C, 84.46; H, 4.52; N, 7.01.
[0263] Synthesis Example 26: Synthesis of Compound 558
[0264]
[0265] Replace a-36 with an equal molar amount of a-519, replace b-36 with an equal molar amount of b-558, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 558 (6.17 g, 73%); HPLC detection of solid purity ≧99.96%. Mass spectrum m / z: 844.2819 (theoretical value: 844.2838). Theoretical element content (%) C 60 H 36 N4O2: C, 85.29; H, 4.29; N, 6.63. Measured element content (%): C, 85.25; H, 4.27; N, 6.69.
[0266] Synthesis Example 27: Synthesis of Compound 573
[0267]
[0268] Replace a-36 with an equal molar amount of a-521, replace b-36 with an equal molar amount of b-107, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 573 (5.60 g, 73%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 766.2638 (theoretical value: 766.2620). Theoretical element content (%) C 56 H 34 N2O2: C, 87.71; H, 4.47; N, 3.65. Measured element content (%): C, 87.77; H, 4.42; N, 3.62.
[0269] Synthesis Example 28: Synthesis of Compound 582
[0270]
[0271] Replace a-36 with an equal molar amount of a-582, replace b-36 with an equal molar amount of b-582, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 582 (5.87 g, 73%); HPLC detection of solid purity ≧99.95%. Mass spectrum m / z: 803.2465 (theoretical value: 803.2477). Theoretical element content (%) C 56 H 29 D5N2S2: C, 83.65; H, 4.89; N, 3.48. Measured element content (%): C, 83.63; H, 4.85; N, 3.53.
[0272] Synthesis Example 29: Synthesis of Compound 585
[0273]
[0274] Replace a-36 with an equal molar amount of a-519, replace b-36 with an equal molar amount of D-191, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 585 (5.18 g, 75%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 690.2318 (theoretical value: 690.2307). Theoretical element content (%) C 50 H 30 N2O2: C, 86.94; H, 4.38; N, 4.06. Measured element content (%): C, 86.90; H, 4.33; N, 4.13.
[0275] Synthesis Example 30: Synthesis of Compound 606
[0276]
[0277] Replace a-36 with an equal molar amount of a-519, replace b-36 with an equal molar amount of b-606, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 606 (5.84 g, 76%); HPLC detection of solid purity ≧99.95%. Mass spectrum m / z: 768.2511 (theoretical value: 768.2525). Theoretical element content (%) C 54 H 32 N4O2: C, 84.36; H, 4.20; N, 7.29. Measured element content (%): C, 84.38; H, 4.15; N, 7.32.
[0278] Synthesis Example 31: Synthesis of Compound 610
[0279]
[0280] Replace a-36 with an equal molar amount of a-610, replace b-36 with an equal molar amount of b-610, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 610 (6.10 g, 75%); HPLC detection of solid purity ≧99.94%. Mass spectrum m / z: 812.2810 (theoretical value: 812.2822). Theoretical element content (%) C 54 H 20 D 12 N4S2: C, 79.77; H, 5.45; N, 6.89. Measured element content (%): C, 79.73; H, 5.48; N, 6.87.
[0281] Synthesis Example 32: Synthesis of Compound 618
[0282]
[0283] Replace a-36 with an equal molar amount of a-618, replace b-36 with an equal molar amount of b-618, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 618 (5.93 g, 74%); HPLC detection of solid purity ≧99.93%. Mass spectrum m / z: 800.2080 (theoretical value: 800.2068). Theoretical element content (%) C 54 H 32 N4S2: C, 80.97; H, 4.03; N, 6.99. Measured element content (%): C, 80.98; H, 4.09; N, 6.94.
[0284] Synthesis Example 33: Synthesis of Compound 626
[0285]
[0286] Replace a-36 with an equal molar amount of a-626, replace b-36 with an equal molar amount of D-610, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 626 (5.15 g, 71%); HPLC detection of solid purity ≧99.90%. Mass spectrum m / z: 725.1725 (theoretical value: 725.1708). Theoretical element content (%) C 47 H 27 N5S2: C, 77.77; H, 3.75; N, 9.65. Measured element content (%): C, 77.73; H, 3.81; N, 9.62.
[0287] Synthesis Example 34: Synthesis of Compound 645
[0288]
[0289] Replace a-36 with an equal molar amount of a-645, replace b-36 with an equal molar amount of b-645, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 645 (5.84 g, 76%); HPLC detection of solid purity ≧99.95%. Mass spectrum m / z: 768.2537 (theoretical value: 768.2525). Theoretical element content (%) C 54 H 32 N4O2: C, 84.36; H, 4.20; N, 7.29. Measured element content (%): C, 84.39; H, 4.26; N, 7.24.
[0290] Synthesis Example 35: Synthesis of Compound 646
[0291]
[0292] Replace a-36 with an equal molar amount of a-519, replace b-36 with an equal molar amount of b-646, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 646 (5.12 g, 74%); HPLC detection of solid purity ≧99.93%. Mass spectrum m / z: 691.2281 (theoretical value: 691.2260). Theoretical element content (%) C 49 H 29 N3O2: C, 85.07; H, 4.23; N, 6.07. Measured element content (%): C, 85.05; H, 4.30; N, 6.04.
[0293] Synthesis Example 36: Synthesis of Compound 649
[0294]
[0295] Replace a-36 with an equal molar amount of a-649, replace b-36 with an equal molar amount of b-176, and the other steps are the same as those in Synthesis Example 3 to obtain Compound 649 (5.54 g, 72%); HPLC detection of solid purity ≧99.91%. Mass spectrum m / z: 768.2517 (theoretical value: 768.2525). Theoretical element content (%) C 54 H 32 N4O2: C, 84.36; H, 4.20; N, 7.29. Measured element content (%): C, 84.32; H, 4.26; N, 7.26.
[0296] The following are other compounds used in the device preparation examples except the carbazole compounds described in the present invention:
[0297]
[0298]
[0299] The test software, computer, K2400 digital source meter of Keithley Company and PR788 spectrum scanning luminance meter of Photo Research Company were combined into a combined IVL test system. The device prepared by the present invention was tested at a current density of 15 mA / cm at atmospheric pressure and room temperature. 2 The luminous efficiency and driving voltage at the time of the device are shown in Table 1 and Table 2. The life of the device prepared by the present invention is tested at atmospheric pressure and room temperature using the M6000 OLED life test system of McScience Company (brightness decays to 95% of the initial brightness). The test results are shown in Table 1 and Table 2.
[0300] Comparative device preparation example 1: Comparative device 1
[0301] First, the ITO / Ag / ITO glass substrate was ultrasonically cleaned twice with deionized water for 20 minutes each time, and then ultrasonically cleaned with isopropanol, acetone and methanol for 20 minutes each, and then exposed to ultraviolet light and ozone for 30 minutes, and finally placed in a vacuum evaporation equipment for use.
[0302] The following layers were deposited layer by layer on the above ITO / Ag / ITO glass substrate: a, HT-14 and p-1 (mass ratio of 100:1) as hole injection layer with a thickness of 10 nm; b, HT-7 as hole transport layer with a thickness of 60 nm; c, HT2-1 as light-emitting auxiliary layer with a thickness of 60 nm; d, RH, HOST-1 and Ir(dpm)PQ2 (mass ratio of 47:47:6) as light-emitting layer with a thickness of 30 nm; d, TPBi as hole blocking layer with a thickness of 10 nm; e, BCP and Liq (mass ratio of 5:5) as electron transport layer with a thickness of 20 nm; f, LiF as electron injection layer with a thickness of 1 nm; g, Mg and Ag (mass ratio of 1:9) as cathode with a thickness of 10 nm; h: CP-4 as covering layer with a thickness of 80 nm.
[0303] Comparative device preparation example 2: Comparative device 2
[0304] The HOST-1 in the light-emitting layer is replaced by HOST-2, and the other steps are the same as those in the comparative device preparation example 1, so as to obtain the comparative device 2.
[0305] Device Preparation Examples 1 to 24: Light Emitting Devices 1 to 24
[0306] The HOST-1 in the light-emitting layer is replaced with the carbazole compounds 36, 59, 110, 191, 288, 301, 317, 357, 420, 477, 519, 521, 546, 550, 555, 558, 582, 585, 606, 610, 618, 626, 645, and 646 of the present invention, respectively, and the other steps are the same as those in the comparative device preparation example 1, to obtain light-emitting devices 1 to 24.
[0307] Table 1
[0308] Device Embodiment Luminescent layer Driving voltage(V) Luminous efficiency (cd / A) Lifespan (h) Comparative device preparation example 1 HOST-1 4.7 28.86 133.7 Comparative device preparation example 2 HOST-2 4.6 29.42 135.1 Device Preparation Example 1 36 4.2 37.49 163.6 Device Preparation Example 2 59 4.3 36.86 165.5 Device Preparation Example 3 110 4.3 37.73 169.2 Device Preparation Example 4 191 4.4 36.95 168.3 Device Preparation Example 5 288 4.2 36.71 159.6 Device Preparation Example 6 301 4.4 37.04 173.4 Device Preparation Example 7 317 4.3 37.65 172.5 Device Preparation Example 8 357 4.2 37.30 162.0 Device Preparation Example 9 420 4.2 37.57 164.5 Device Preparation Example 10 477 4.2 38.49 162.9 Device Preparation Example 11 519 4.2 38.27 166.6 Device Preparation Example 12 521 4.2 38.35 174.2 Device Preparation Example 13 546 4.2 36.78 161.1 Device Preparation Example 14 550 4.3 37.99 178.6 Device Preparation Example 15 555 4.3 38.90 171.4 Device Preparation Example 16 558 4.4 37.18 177.5 Device Preparation Example 17 582 4.1 39.04 179.8 Device Preparation Example 18 585 4.3 38.13 170.3 Device Preparation Example 19 606 4.3 38.75 176.7 Device Preparation Example 20 610 4.1 39.17 181.1 Device Preparation Example 21 618 4.2 37.41 175.0 Device Preparation Example 22 626 4.1 37.11 160.2 Device Preparation Example 23 645 4.3 38.61 175.9 Device Preparation Example 24 646 4.2 37.85 167.5
[0309] Comparative device preparation example 3: Comparative device 3
[0310] First, the ITO / Ag / ITO glass substrate was ultrasonically cleaned twice with deionized water for 20 minutes each time, and then ultrasonically cleaned with isopropanol, acetone and methanol for 20 minutes each, and then exposed to ultraviolet light and ozone for 30 minutes, and finally placed in a vacuum evaporation equipment for use.
[0311] The following layers were deposited layer by layer on the above ITO / Ag / ITO glass substrate: a, HT-14 and p-1 (mass ratio of 100:1) as hole injection layer with a thickness of 10 nm; b, HT-7 as hole transport layer with a thickness of 60 nm; c, HT2-2 as light-emitting auxiliary layer with a thickness of 60 nm; d, GH, HOST-3 and Ir(ppy)2(m-bppy) (mass ratio of 32:64:4) as light-emitting layer with a thickness of 35 nm; e, TPBi as hole blocking layer with a thickness of 10 nm; f, BCP and Liq (mass ratio of 5:5) as electron transport layer with a thickness of 20 nm; g, LiF as electron injection layer with a thickness of 1 nm; h, Mg and Ag (mass ratio of 1:9) as cathode with a thickness of 10 nm; i: CP-4 as covering layer with a thickness of 80 nm.
[0312] Comparative device preparation examples 4 to 5: Comparative devices 4 to 5
[0313] The HOST-3 in the light-emitting layer is replaced by HOST-4 and HOST-5 respectively, and the other steps are the same as those in the comparative device preparation example 3, so that comparative devices 4 to 5 can be obtained.
[0314] Device Preparation Examples 25 to 34: Light Emitting Devices 25 to 34
[0315] The HOST-3 in the light-emitting layer is replaced with the carbazole compounds 95, 107, 145, 176, 435, 466, 467, 506, 573, and 649 of the present invention, respectively, and the other steps are the same as those in the comparative device preparation example 3, to obtain light-emitting devices 25 to 34.
[0316] Table 2
[0317] Device Embodiment Luminescent layer Driving voltage(V) Luminous efficiency (cd / A) Lifespan (h) Comparative device preparation example 3 HOST-3 4.7 36.14 123.5 Comparative device preparation example 4 HOST-4 4.6 35.80 119.3 Comparative device preparation example 5 HOST-5 4.8 35.62 112.6 Device Preparation Example 25 95 4.3 44.22 148.5 Device Preparation Example 26 107 4.1 44.53 151.8 Device Preparation Example 27 145 4.2 44.37 153.3 Device Preparation Example 28 176 4.1 45.18 154.9 Device Preparation Example 29 435 4.3 44.65 151.1 Device Preparation Example 30 466 4.3 44.79 149.3 Device Preparation Example 31 467 4.4 44.09 150.2 Device Preparation Example 32 506 4.4 45.34 159.4 Device Preparation Example 33 573 4.2 44.96 155.7 Device Preparation Example 34 649 4.2 45.58 157.5
[0318] The device data in Table 1 and Table 2 show that the carbazole compounds of the present invention are used as the main material of the light-emitting layer in OLED devices, which can greatly improve the luminous efficiency, service life and driving voltage. In summary, the carbazole compounds provided by the present invention are a class of OLED materials with excellent performance and have good application prospects.
[0319] It should be noted that the present invention is particularly described using individual embodiments. However, without departing from the principles of the present invention, a person skilled in the art may make various improvements in form or detail to the present invention, and these improvements also fall within the scope of protection of the present invention.
Claims
1. A carbazole compound, characterized in that: It has the structure shown in formula (I): Wherein, the ring A, ring B, and ring C are independently selected from a substituted or unsubstituted C6-C30 aromatic ring, a substituted or unsubstituted C2-C30 heteroaromatic ring, and a ring formed by fusion of a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring; The X1 and X2 are independently selected from a single bond, O, S, CR a R b or NL-Ar, and at least one of them is not a single bond, the L is selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, a substituted or unsubstituted C3-C20 aliphatic ring fused with a C6-C30 aromatic ring; the R a , R b , Ar is independently selected from a substituted or unsubstituted C1-C20 straight or branched alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, a substituted or unsubstituted silyl group, a substituted or unsubstituted C6-C30 aryl group, a substituted or unsubstituted C2-C30 heteroaryl group, a substituted or unsubstituted C3-C20 aliphatic ring fused with a C6-C30 aromatic ring, or the R a , R b Can bond to each other to form a substituted or unsubstituted saturated or unsaturated C3-C6 ring; The Ar1 and Ar2 are independently selected from one of the following groups: wherein X is selected from O, S or N-R2 at each occurrence, the same or different; Y is selected from N or C-R3 at each occurrence, the same or different; R1, R2, R3 are selected from hydrogen atom, deuterium atom, halogen atom, cyano group, substituted or unsubstituted C1-C20 straight chain or branched alkyl group, substituted or unsubstituted C3-C20 cycloalkyl group, substituted or unsubstituted silyl group, substituted or unsubstituted C6-C30 aryl group, substituted or unsubstituted C2-C30 heteroaryl group, substituted or unsubstituted C3-C20 aliphatic ring and C6-C30 aromatic ring fused monovalent group at each occurrence; Ring E is selected from substituted or unsubstituted C6-C30 aromatic ring, substituted or unsubstituted C3-C20 aliphatic ring and C6-C30 aromatic ring fused ring at each occurrence, the same or different; The Cy is selected from a substituted or unsubstituted C6-C30 aromatic ring, a substituted or unsubstituted C2-C30 heteroaromatic ring, and a ring formed by fusion of a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring; The L1, L2, and L3 are independently selected from a single bond, a substituted or unsubstituted C6-C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, and a divalent group formed by condensing a substituted or unsubstituted C3-C20 aliphatic ring and a C6-C30 aromatic ring.
2. The carbazole compound according to claim 1, characterized in that Has one of the following structures:
3. The carbazole compound according to claim 1, characterized in that The Ar1 and Ar2 are independently selected from one of the following groups: Wherein, each occurrence of X is the same or different selected from O, S or N-R2; each occurrence of Y is the same or different selected from N or C-R3; Each time a0 appears, it is selected from 0, 1, 2, 3 or 4 in the same or different manner; each time b0 appears, it is selected from 0, 1, 2, 3, 4, 5 or 6 in the same or different manner; each time c0 appears, it is selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8 in the same or different manner; each time d0 appears, it is selected from 0, 1, 2 or 3 in the same or different manner; each time e0 appears, it is selected from 0, 1 or 2 in the same or different manner; The R1, R2, R3, R Z Each time it occurs, it is identically or differently selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a substituted or unsubstituted C1-C12 straight or branched alkyl group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted silyl group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C20 heteroaryl group, and a monovalent group formed by a substituted or unsubstituted C3-C10 aliphatic ring and a C6-C20 aromatic ring.
4. The carbazole compound according to claim 1, characterized in that The Cy is selected from a substituted or unsubstituted C6-C18 aromatic ring, a substituted or unsubstituted C2-C18 heteroaromatic ring, and a ring formed by fusion of a substituted or unsubstituted C3-C7 aliphatic ring and a C6-C18 aromatic ring.
5. The carbazole compound according to claim 1, characterized in that The Selected from one of the following groups: Wherein, each time a appears, it is selected from 0, 1, 2, 3 or 4 in the same or different manner; each time b appears, it is selected from 0, 1 or 2 in the same or different manner; each time c appears, it is selected from 0, 1, 2 or 3 in the same or different manner; each time d appears, it is selected from 0 or 1 in the same or different manner; The R1, R3, R Z Each occurrence is identically or differently selected from a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, a cyclopropane group, a cyclobutane group, a cyclopentane group, a cyclohexane group, an adamantyl group, a norbornyl group, a phenyl group, a deuterated phenyl group, a fluorine-substituted phenyl group, a methyl-substituted phenyl group, a tert-butyl-substituted phenyl group, a cyano-substituted phenyl group, a biphenyl group, a deuterated biphenyl group, a methyl-substituted biphenyl group, a tert-butyl-substituted biphenyl group, a naphthyl group, One of deuterated naphthyl, anthracenyl, deuterated anthracenyl, phenanthryl, deuterated phenanthryl, pyridyl, deuterated pyridyl, pyrimidinyl, deuterated pyrimidinyl, diphenylpyrimidinyl, quinolyl, deuterated quinolyl, isoquinolyl, deuterated isoquinolyl, quinoxalinyl, phenyl-substituted quinoxalinyl, quinazolinyl, phenyl-substituted quinazolinyl, benzofuranyl, deuterated benzofuranyl, benzothienyl, deuterated benzothienyl, indanyl, deuterated indanyl, tetrahydronaphthyl, deuterated tetrahydronaphthyl, and trimethylsilyl; The R2 described above, when it appears each time, is identically or differently selected from methyl, deuterated methyl, trifluoromethyl, ethyl, isopropyl, tert-butyl, deuterated tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, deuterated phenyl, fluorine-substituted phenyl, methyl-substituted phenyl, tert-butyl-substituted phenyl, cyano-substituted phenyl, biphenyl, deuterated biphenyl, methyl-substituted biphenyl, tert-butyl-substituted biphenyl, naphthyl, deuterated naphthyl, anthracenyl, deuterated anthracenyl, phenanthryl, deuterated phenanthryl, pyridyl, deuterated pyridyl, pyrimidinyl, deuterated pyrimidinyl, diphenylpyrimidinyl, quinolyl, deuterated quinolyl, isoquinolyl, deuterated isoquinolyl, quinoxalinyl, phenyl-substituted quinoxalinyl, quinazolinyl, phenyl-substituted quinazolinyl, benzofuranyl, deuterated benzofuranyl, benzothienyl, deuterated benzothienyl, indanyl, deuterated indanyl, tetrahydronaphthyl, deuterated tetrahydronaphthyl, trimethylsilyl; The a 11 Each time it occurs, it is selected from 0, 1, 2 or 3, either identically or differently; The R 11 Each occurrence is identically or differently selected from one of a hydrogen atom, a deuterium atom, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, and a trimethylsilyl group; Each time L2 and L3 appear, they are identical or different and are selected from a single bond or one of the following groups: Among them, the a 21 Each occurrence is identically or differently selected from 0, 1, 2, 3 or 4; said b 21 Each time it occurs, it is selected from 0, 1, 2 or 3 identically or differently; 21 Each occurrence is identically or differently selected from 0, 1 or 2; said d 21 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5 or 6; said e 21 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; The R 21 , R 22 Each time it occurs, it is identically or differently selected from one of the group consisting of a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, a cyclopropane group, a cyclobutane group, a cyclopentane group, a cyclohexane group, an adamantyl group, a norbornyl group, and a trimethylsilyl group.
6. The carbazole compound according to claim 1, characterized in that The R a , R b , Ar is independently selected from methyl, deuterated methyl, trifluoromethyl, ethyl, n-propyl, isopropyl, deuterated isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, deuterated tert-butyl, One of the following groups: Among them, the a 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4 or 5; said b 31 Each occurrence is identically or differently selected from 0, 1, 2, 3 or 4; said c 31 Each occurrence is identically or differently selected from 0, 1, 2 or 3; said d 31 Each occurrence is identically or differently selected from 0, 1 or 2; said e 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5 or 6; said f 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; said g 31 Each time it occurs, it is selected from 0 or 1 identically or differently; 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5 or 6; said i 31 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; The R 31 Each occurrence is identically or differently selected from one of the group consisting of a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, an adamantyl group, a norbornyl group, a phenyl group, a deuterated phenyl group, a fluorine-substituted phenyl group, a methyl-substituted phenyl group, a tert-butyl-substituted phenyl group, a cyano-substituted phenyl group, a naphthyl group, a deuterated naphthyl group, an indanyl group, a deuterated indanyl group, a tetrahydronaphthyl group, a deuterated tetrahydronaphthyl group, a pyridyl group, a deuterated pyridyl group, a pyrimidyl group, a deuterated pyrimidyl group, a trimethylsilyl group, and a triphenylsilyl group; The R 32 Each occurrence is identically or differently selected from one of hydrogen, deuterium, fluorine, cyano, methyl, deuterated methyl, trifluoromethyl, ethyl, isopropyl, tert-butyl, deuterated tert-butyl, cyclopropane, cyclobutane, cyclopentane, cyclohexane, adamantyl, and norbornyl; The R 33 Each occurrence is identically or differently selected from one of the following: methyl, deuterated methyl, trifluoromethyl, ethyl, isopropyl, tert-butyl, deuterated tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, deuterated phenyl, fluorine-substituted phenyl, methyl-substituted phenyl, tert-butyl-substituted phenyl, cyano-substituted phenyl, biphenyl, deuterated biphenyl, fluorine-substituted biphenyl, methyl-substituted biphenyl, tert-butyl-substituted biphenyl, cyano-substituted biphenyl, naphthyl, deuterated naphthyl, indanyl, deuterated indanyl, tetrahydronaphthyl, deuterated tetrahydronaphthyl, pyridyl, deuterated pyridyl, pyrimidinyl, deuterated pyrimidinyl, trimethylsilyl, triphenylsilyl.
7. The carbazole compound according to claim 1, characterized in that Each time L1 and L appear, they are identical or different and are selected from a single bond or one of the following groups: Among them, the a 41 Each occurrence is identically or differently selected from 0, 1, 2, 3 or 4; said b 41 Each time it occurs, it is selected from 0, 1, 2 or 3, the same or different; 41 Each occurrence is identically or differently selected from 0, 1 or 2; said d 41 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5 or 6; said e 41 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7 or 8; said f 41 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; said g 41 Each occurrence is identically or differently selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14; The R 41 Each occurrence is identically or differently selected from one of the group consisting of a hydrogen atom, a deuterium atom, a fluorine atom, a cyano group, a methyl group, a deuterated methyl group, a trifluoromethyl group, an ethyl group, an isopropyl group, a tert-butyl group, a deuterated tert-butyl group, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, an adamantyl group, a norbornyl group, a phenyl group, a deuterated phenyl group, a fluorine-substituted phenyl group, a methyl-substituted phenyl group, a tert-butyl-substituted phenyl group, a cyano-substituted phenyl group, a naphthyl group, a deuterated naphthyl group, an indanyl group, a deuterated indanyl group, a tetrahydronaphthyl group, a deuterated tetrahydronaphthyl group, a pyridyl group, a deuterated pyridyl group, a pyrimidyl group, a deuterated pyrimidyl group, a trimethylsilyl group, and a triphenylsilyl group; The R 42 Each occurrence is identically or differently selected from one of hydrogen, deuterium, fluorine, cyano, methyl, deuterated methyl, trifluoromethyl, ethyl, isopropyl, tert-butyl, deuterated tert-butyl, cyclopropane, cyclobutane, cyclopentane, cyclohexane, adamantyl, and norbornyl; The R 43 Each occurrence is identically or differently selected from one of the following: methyl, deuterated methyl, trifluoromethyl, ethyl, isopropyl, tert-butyl, deuterated tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, deuterated phenyl, fluorine-substituted phenyl, methyl-substituted phenyl, tert-butyl-substituted phenyl, cyano-substituted phenyl, biphenyl, deuterated biphenyl, fluorine-substituted biphenyl, methyl-substituted biphenyl, tert-butyl-substituted biphenyl, cyano-substituted biphenyl, naphthyl, deuterated naphthyl, indanyl, deuterated indanyl, tetrahydronaphthyl, deuterated tetrahydronaphthyl, pyridyl, deuterated pyridyl, pyrimidinyl, deuterated pyrimidinyl, trimethylsilyl, triphenylsilyl.
8. The carbazole compound according to claim 1, characterized in that The carbazole compound is selected from one of the following compounds:
9. An organic electroluminescent device, comprising an anode, a cathode and an organic functional layer, wherein the organic functional layer comprises one or more of a hole transport region, a light-emitting layer, an electron transport region, and a covering layer on the side of the cathode facing away from the anode, wherein: The organic functional layer contains at least one of the carbazole compounds described in any one of claims 1 to 8.
10. The organic electroluminescent device according to claim 9, wherein the organic functional layer comprises a hole transport region, a light emitting layer, and an electron transport region located between the anode and the cathode, wherein: The light-emitting layer contains at least one of the carbazole compounds according to any one of claims 1 to 8.
